Suchen Sie nach Informationen zu Firmensitznummer Von Grifols? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.


Home Page Official

    https://www.grifols.com/en/home
    Innovating for patients and society. Since our founding in 1909, we have applied our ever-growing mastery of plasma science, our ethical leadership and best-in-industry- quality and safety standards to make a healthier and more sustainable society. Read more.

Grifols Inc. Company Profile | Clayton, NC | Competitors, …

    https://www.dnb.com/business-directory/company-profiles.grifols_inc.b87ba9187f73ba0c1e89e4c1c379a49a.html
    Company Description: Grifols Inc. is located in Clayton, NC, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Grifols Inc. has 112 total employees across all of its locations and generates $15.59 million in sales (USD). (Employees and Sales figures are modelled).

Grifols Deutschland GmbH, Frankfurt a. Main, Germany - North Data

    https://www.northdata.com/Grifols+Deutschland+GmbH,+Frankfurt+a.+Main/Amtsgericht+Frankfurt+am+Main+HRB+76336
    Grifols Deutschland GmbH, Frankfurt a. Main, Germany, District Court of Frankfurt HRB 76336: Revenue, Taxes, Earnings, Employees, Network, Financial information

Grifols Company Profile - Office Locations, Competitors …

    https://craft.co/grifols
    Rua Werner Von Siemens, 111 - Lapa de Baixo. Mississauga, CA. 405 5060 Spectrum Way. Show all (38) Report incorrect company information. ... Grifols's key executives are Raimon Grifols Roura, Victor Grifols Deu and Thomas Glanzmann. How many employees does Grifols have? Grifols has 23,245 employees.

GRIFOLS SA Company Profile | BARCELONA, Spain - Dun …

    https://www.dnb.com/business-directory/company-profiles.grifols_sa.d01e8c5c28ca931d3d424ef7dbf6ae19.html
    Cash Flow (mil) 2021 2020 2019; Net Operating Cash: $676 $1,257 $644 Net Investing Cash-$967 -$971

Investors | Grifols

    https://www.grifols.com/en/investors
    June 10, 2022. Grifols highlights an increase in plasma and underscores innovation and sustainability as key growth pillars in its AGM. Read more. May 6, 2022. Business Update 1Q 2022: Grifols accelerating plasma recovery while enhancing performance. Read more. April 25, 2022. Grifols completes the acquisition of Biotest: a strategic and ...

GRIFOLS, S.A. : Shareholders Board Members Managers …

    https://www.marketscreener.com/quote/stock/GRIFOLS-S-A-25530961/company/
    Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows:

GRIFOLS, S.A. - MarketScreener.com

    https://www.marketscreener.com/quote/stock/GRIFOLS-S-A-25530828/company/
    Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows:

Grifols S.A. (GRFS) Company Profile & Overview - Stock …

    https://stockanalysis.com/stocks/grfs/company/
    Company Description. Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and ...

Grifols SA - Company Profile and News - Bloomberg …

    https://www.bloomberg.com/profile/company/GRF:SM
    Company profile page for Grifols SA including stock price, company news, press releases, executives, board members, and contact information

Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Firmensitznummer Von Grifols gefunden haben.